Bitcoin price today: drops to $67k as traders await US jobs data for Fed rate cues
Bitcoin price today: drops to $67k as traders await US jobs data for Fed rate cues
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
Coinbase, Robinhood and Circle are expanding into stablecoins, payments and prediction markets, but their latest earnings show how hard it is to escape cry...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Bitcoin price today: drops to $67k as traders await US jobs data for Fed rate cues
Crypto political action committee Fairshake spent roughly $130 million during the 2024 US elections to support pro-crypto candidates.
Spark is opening access to its $9 billion stablecoin liquidity pool for hedge funds and other institutions to bridge onchain capital with off-chain credit...
Hong Kong's Securities and Futures Commission will publish a "high-level framework" allowing perpetual contracts, SFC CEO Julia Leung said.
"We bought a house outright for $500,000. We each contributed $250,000."
Don't let the global memory shortage distract you from the upcoming Apple Intelligence launch, according to Bernstein.
Wall Street is gearing up for a closely watched jobs report amid a cooling labor market.
Fair value for the cryptocurrency is currently about $55,000.
Amazon's post-earnings pullback resulted in a big slide for this geared ETF, reminding investors of the risks associated with these funds.
Boeing plans to open fourth 737 production line in midsummer
Australian bank CBA posts record first-half cash earnings on lending growth
'It's not an easy pill to take': The first highly anticipated GLP-1 pill is here, but physicians aren't sure it has the staying power of the injections